Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2026)
Xeris Biopharma Holdings' (XERS) Asset Utilization Ratio stood at 0.83 in Q2 2026, up 10.3% from 0.76 a year earlier and up 2.8% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Starting with Q4 2021, Xeris Biopharma Holdings' Asset Utilization Ratio history includes 19 quarters.
- Annual Asset Utilization Ratio has increased for four straight years.
- Across earlier years, Asset Utilization Ratio came in at 0.63 in FY2024 (+28.0%), 0.49 in FY2023 (+44.6%), 0.34 in FY2022 (+58.8%) and 0.21 in FY2021.
- The Q2 2026 figure is the highest quarterly Asset Utilization Ratio in data going back to Q4 2021.
- On a year-over-year basis, Asset Utilization Ratio has increased for 15 consecutive quarters, with growth averaging 25.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Asset Utilization Ratio ran from 10.3% in Q2 2026 to 84.4% in Q1 2023.
- Per Business Quant, the preceding three quarters came in at 0.81 (Q1 2026), 0.77 (Q4 2025) and 0.76 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.48 Bn | 1,106.07 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 618.81 Bn | 537.34 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 236.67 Bn | 192.07 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.16 Bn | 165.36 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 169.69 Bn | 116.34 Bn | 10.94 Bn | 0.31 |
| 10 | Xeris Biopharma Holdings | 1.88 Bn | 1.45 Bn | 79.59 Mn | 0.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.83 |
| Mar 31, 2026 | 0.81 |
| Dec 31, 2025 | 0.77 |
| Sep 30, 2025 | 0.76 |
| Jun 30, 2025 | 0.76 |
| Mar 31, 2025 | 0.70 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.57 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 0.52 |
| Dec 31, 2023 | 0.50 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.36 |
| Dec 31, 2022 | 0.34 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.23 |
API Access
Xeris Biopharma Holdings Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();